An interventional study of Catheter ablation in Heart Arrhythmia, Heart Diseases and Arrhythmias, Cardiac, sponsored by Evangelical Hospital Düsseldorf. Recruiting at 6 sites in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-30.
Sponsored by Evangelical Hospital Düsseldorf · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 94 studies in Arrhythmias, Cardiac with a site in Germany — 15 open to participants now, 19 under way, none of them phase 3. Arrhythmias, Cardiac · Germany.
Among the 94 studies in Arrhythmias, Cardiac with a site in Germany, this one is the 31st largest by planned enrollment of the 48 interventional ones that give a count, is one of 6 that started in 2020, is one of 28 with no phase, reaches primary completion later than 9 of the 18 other live ones, and was the 73rd registered.
1,052 studies on the registry are indexed under Arrhythmias, Cardiac; 236 are open to participants now.
Browse Arrhythmias, Cardiac studies →15 of the 94 studies in Arrhythmias, Cardiac with a site in Germany are open now. Recruiting first, the newest first:
Biosense Webster, Inc. · Sites in Germany, Austria, Belgium
Ages 18+
Biotronik, Inc. · Sites in Germany, United States, Australia and 5 more countries
Ages 18+
Insel Gruppe AG, University Hospital Bern · Sites in Germany, Australia, Bulgaria and 4 more countries
Ages 18+
Novartis Pharmaceuticals · Sites in Germany, United States, Canada and 4 more countries
Ages 18+
Biotronik SE & Co. KG · Sites in Germany, Belgium
Ages 18+
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 167 Arrhythmias, Cardiac studies recruiting now, 119 (71%) set no upper age limit and 13 (8%) stop at 75 or younger; 31 take children under 18; 26 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
94 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 8 · Phase 3 12 · Phase 4 3
First in 1983; this study’s year is marked. 6 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is close to the median of 100 across 518 interventional studies indexed under Arrhythmias, Cardiac.
Median enrollment 210 across the 48 interventional studies, 572 across the 44 observational. Of the 61 that completed or were terminated, 19 (31%) have results posted.
This tab as a report to print or save as PDF → With an account.
50 of 94 have an industry lead sponsor. The 10 most frequent:
Evangelical Hospital Düsseldorf is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Evangelical Hospital Düsseldorf has 1 study filed under Arrhythmias, Cardiac — fewer than ten, so there is no comparison to draw.
6 of the studies in Arrhythmias, Cardiac with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04735016Medtronic Cardiac Ablation SolutionsDiamondTemp Global Registry | 2026-12-31 |
| NCT07118358Biotronik, Inc.BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System | 2027-03 |
| NCT06083012Volta MedicalClinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation | 2027-04-27 |
| NCT05239364Evangelical Hospital DüsseldorfAblation of Consecutive Atrial Tachycardia | 2027-06 |
| NCT07217067Novartis PharmaceuticalsA Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation | 2027-09-09 |
Add all 6 to your calendar (.ics) → With an account.
Among the 94 studies in Arrhythmias, Cardiac with a site in Germany, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Ablation of consecutive atrial tachycardia (AT) after ablation of atrial fibrillation (AF) or cardiac surgery can be challenging due to complex substrate and AT mechanisms. A substantial portion of patients is known to show various tachycardias and recurrences occur in a noticeable number of cases. With the availability of novel ultra-high-density mapping techniques characterization and understanding of AT mechanisms and underlying substrate can be improved. Aim of this prospective, multi-center, randomized study is to compare a standard AT ablation approach versus minimalized ablation of the clinical AT in regards to arrhythmia free survival.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
ECG (electrocardiogram)
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients will receive a standard approach for ablation of atrial tachycardia.
Procedure: Catheter ablation
Patients will receive a minimalized approach for ablation of atrial tachycardia.
Procedure: Catheter ablation
Catheter-based ablation of arrhythmias using radiofrequency.
Recurrence of any sustained arrhythmia (>30 sec.)
Time frame: 1 year
Inducibility of atrial tachycardia (AT) after ablation of clinical/primary AT (partial success)
Categorical variable (yes/no)
Time frame: Intraprocedural
Predictability of secondary AT by analysis of clinical AT map and voltage map
Time frame: Intraprocedural
Procedure duration time
Time frame: Intraprocedural
Fluoroscopy time
Time frame: intraprocedural
Total radiofrequency application time
Time frame: intraprocedural
Ablated area (cm2)
Time frame: intraprocedural
Number of blocked lines
Time frame: intraprocedural
Area of low voltage in sinus map (cm2)
Time frame: Intraprocedural
Plan to share: No
Started Dec 2020 (actual). Primary completion is estimated for Jun 2027, 78 months after the start.
Of 172 non-industry interventional studies with no phase under Arrhythmias, Cardiac, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 43. This study's planned 78 months is above that.
Counting every sponsor, half of 243 studies reached it within 24 months; a quarter within 12 and three quarters within 40.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Evangelical Hospital Düsseldorf